Mankind Pharma Limited (BOM:543904)
India flag India · Delayed Price · Currency is INR
2,469.90
-107.05 (-4.15%)
At close: Jul 31, 2026

Mankind Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
1,019,935828,0511,000,400921,654--
Market Cap Growth
-4.05%-17.23%8.54%---
Enterprise Value
1,063,581879,179960,198902,241--
Last Close Price
2469.902005.852422.202296.45--

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
49.9343.2950.2548.18--
PS Ratio
6.925.808.208.98--
PB Ratio
6.165.006.879.63--
P/TBV Ratio
612.21497.03-12.00--
P/FCF Ratio
40.8733.1851.2450.17--
P/OCF Ratio
32.6826.5341.4542.82--

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
7.226.167.878.79--
EV/EBITDA Ratio
27.0624.2231.0735.87--
EV/EBIT Ratio
35.0631.1938.2841.96--
EV/FCF Ratio
42.6235.2349.1849.11--

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.380.380.580.020.020.14
Debt / EBITDA Ratio
1.611.732.740.080.090.44
Debt / FCF Ratio
-2.534.360.110.171.94
Net Debt / Equity Ratio
0.250.250.41-0.33-0.18-0.06
Net Debt / EBITDA Ratio
1.061.131.95-1.26-0.71-0.20
Net Debt / FCF Ratio
-1.653.08-1.73-1.32-0.87
Asset Turnover
-0.510.620.950.931.00
Inventory Turnover
-2.012.012.171.841.69
Quick Ratio
-0.610.722.021.140.65
Current Ratio
-1.071.233.102.321.68
Return on Equity (ROE)
-12.45%16.62%22.57%18.79%25.99%
Return on Assets (ROA)
-6.31%7.89%12.40%10.53%14.76%
Return on Invested Capital (ROIC)
11.80%11.36%14.83%27.47%20.42%29.77%
Return on Capital Employed (ROCE)
-13.10%11.40%21.80%20.20%28.10%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
2.00%2.31%1.99%2.08%--
FCF Yield
2.45%3.01%1.95%1.99%--
Payout Ratio
-2.16%----
Buyback Yield / Dilution
-1.36%-2.13%-0.88%-0.14%-0.00%-
Total Shareholder Return
-1.32%-2.13%-0.88%-0.14%-0.00%-